A University of Alabama at Birmingham pediatric neurosurgeon has performed the first deep brain stimulation (DBS) procedure for epilepsy at Children’s of Alabama (COA), offering a new treatment option ...

Responsive neurostimulation (RNS) is an implantable therapy for patients whose focal epilepsy remains refractory to antiepileptic drugs. Electrodes are placed at putative seizure foci and continuously ...

CLEARWATER — It’s easier to feel than to see the slight bump on Emma Coto’s head. It comes from a small electrical device, reminiscent of the bottom half of an old flip phone, that doctors implanted ...

Precision neurostimulation leverages AI and closed-loop feedback, delivering tailored treatments for neurological disorders ...

Cantor Fitzgerald initiated coverage on NeuroPace Inc (NASDAQ:NPCE), a commercial-stage medical device company focused on drug-resistant epilepsy treatment through the company's responsive ...

On June 18, neurosurgeons at the University of Alabama at Birmingham implanted a new type of electrical stimulator to control seizures in patients with difficult-to-control epilepsy. It marked the ...

Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy, affecting a significant proportion of patients who develop drug-resistant epilepsy. Surgical interventions, particularly ...

HOUSTON, TEXAS, March 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation ...

Emma Coto and her family met with doctor after doctor looking for answers. They found them at Boston Children’s Hospital. Emma Coto, 11, plays the piano during a Christmas recital at The Music Gallery ...